1. Market Research
  2. > Biotechnology Market Trends
  3. >Genetically Modified Organism

Latest GMO Industry Statistics & Trends

  • Currently3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
21 votes

Global Genetically Modified Organisms Industry Statistics

Theglobal genetic testing industryis expected to be worth $2.2 billion by 2017,according to research from Global Industry Analysts.Market growth is fuelled by awareness regarding the advantages of genetic testing.Developments in the sector are also driven by increasing cases of chronic diseases,rising numbers of patients suffering from cancer and an aging global population.The US dominates the global genetic testing industry.

The genetically modified organism industry involves the creation of new sets of genes for insertion into an organism.These organisms have many applications,including adaption of foods such as is the case with transgenic plants that have been modified to better survive pests and herbicides or to boost shelf-life and nutritional value.Other areas in which genetically modified organisms are used apart from agriculture include gene therapy,medical research and the manufacture of pharmaceuticals.

Key Market Segments

Theglobal gene amplification technology marketis expected to reach $2.2 billion by 2017,reports Global Industry Analysts.The Human Genome Project greatly benefited the sector and,along with molecular diagnostics,continues to fuel market expansion.Gene amplification technology market growth is also being driven by an aging population and increases of age-related diseases.The US dominates the global market.Gene Amplification Technology touches on different life sciences disciplines,including diagnosis,drug discovery,forensic identification and molecular biology research.Polymerase Chain Reactionrepresents a significant segment in the field of gene amplification,recording strong growth over the past few years.

Theglobal synthetic biology marketrepresents a leading discipline within biotechnology with many applications.BCC Research points to commercial opportunities for synthetic biology such as enzymes,specialty chemicals,biofuels,synthetic genes,chassis microorganisms and pharmaceuticals.Synthetic biology overlaps with other industry like chemicals,biotechnology,diagnostics,pharmaceuticals,chemicals and life science tools.

Synthetic biology marketgrowth is being fuelled by technological developments in DNA synthesis and sequencing,demand for renewable feedstock,bioinformatics and specialty media.

Theglobal industrial enzymes marketreached close to $3.5 billion in 2010,according to research from BCC Research.The market is forecast to record yearly growth in excess of 5% over the coming years to hit almost $4.5 billion by 2015.Technical enzymes represent a leading market segment,expected to record yearly growth of almost 7%,with expected worth set to reach $1.5 billion in 2015.Technical enzyme sales were highest in the leather market,and second-highest in the bioethanol sector.The food and beverage enzyme market segment is forecast to record yearly growth in excess of 5% to reach $1.3 billion by 2015,up from under $1 billion in 2010.Milk and dairy recorded the highest sales in the food and beverage enzyme market,exceeding $400 million in 2009.

Industry Leaders

Leading companies operating in the genetic engineering market includeBioRad Laboratories,Transgenomic,,Applied Biosystems,Roche Diagnostics,Abbott Laboratories,,Celera,PerkinElmer,,Roche Molecular Diagnostics,ELITech,Abbott Molecular,Quest Diagnostics and AutoGenomics.

Read more »

You might be interested in these related markets:

Customer Support

Talk toSam

+33 4 37 65 17 06

32 Reports
59 Statistics
Market Size,Supply,Demand
82 Reports
84 Statistics
Market Size,Supply,Demand
38 Reports
62 Statistics
Market Size,Supply,Demand
13 Reports
2 Statistics
Market Size,Supply,Demand
11 Reports
7 Statistics
Supply,Market Size,Demand
10 Reports
2 Statistics
Market Size,Supply,Demand
45 Reports
Supply,Risk Assessment,Demand
35 Statistics
Market Size,Supply,Demand
9 Reports
14 Statistics
Market Size,Supply,Demand
8 Reports
4 Statistics
Market Size,Supply,Trade
4 Reports
10 Statistics
Market Size,Supply,Demand
Search in Genetically Modified Organism Industry (About 1800 reports)
Parent industry: Biotechnology
Related industries: Biological Therapy,, Biomaterial,, Biopharmaceutical,, Genomics

About 100 reports

Purchase Reports From Reputable Market Research Publishers

Drug Overview: Rubraca

Drug Overview: Rubraca

  • € 8770
  • Industry report
  • January 2018

Drug OverviewRubraca (rucaparib) is a small molecule poly (ADP-ribose) polymerase (PARP) inhibitor developed by Clovis Oncology for the treatment of recurrent ovarian cancer patients with known BRCA mutations ...

Drug Analysis: Rubraca € 8770 January 2018

Drug analysis: Gleevec € 8770 December 2017

Drug analysis: Sprycel € 8770 December 2017

Recombinant DNA Technology Market Analysis By Product,... € 5218 August 2017

GMO Crops and Seeds Industry: Forecasts to 2022 € 5082 September 2017

Food Testing Kits Market: Target until 2022 € 5045 January 2018

Synthetic Biology Market: Global Forecast until 2022 € 5045 December 2017

Rapid Test Market: Global Forecast until 2022 € 5045 September 2017

Competent Cells Market: Global Forecast until 2022 € 5045 July 2017

澳门金沙平台游戏.com © Copyright 2018.All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don't miss any news and follow us on